Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/14/2022 | Intellia Therapeutics, Inc. | NTLA | Grant | | 5.2k | $0.00 | $0 | | 06/14/2022 |
06/14/2022 | Intellia Therapeutics, Inc. | NTLA | Grant | Stock Option (right to buy) | 7.7k | $38.49 | $295.9k | | 06/14/2022 |
06/09/2022 | Ikena Oncology, Inc. | | Grant | Stock Option (Right to Buy) | 13.4k | $4.85 | $65.1k | | 06/09/2022 |
12/21/2021 | Ikena Oncology, Inc. | | Grant | Stock Option (Right to Buy) | 13.4k | $14.92 | $200.2k | | 12/21/2021 |
12/14/2021 | Ikena Oncology, Inc. | | Sale | Common Stock | 6k | $14.00 | $83.4k | See footnote | 03/30/2021 |
12/13/2021 | Ikena Oncology, Inc. | | Sale | Common Stock | 8.3k | $14.64 | $122k | See footnote | 03/30/2021 |
12/10/2021 | Ikena Oncology, Inc. | | Sale | Common Stock | 12k | $15.03 | $180.2k | See footnote | 03/30/2021 |
09/14/2021 | Translate Bio, Inc. | TBIO | Sale | Common Stock | 2.1M | $38.00 | $78.1M | See Footnote | 09/14/2021 |
09/14/2021 | Translate Bio, Inc. | TBIO | Sale | Stock Option (right to buy) | 18.9k | $10.20 | $192.8k | | 09/14/2021 |
09/14/2021 | Translate Bio, Inc. | TBIO | Sale | Stock Option (right to buy) | 18.9k | $15.33 | $289.7k | | 09/14/2021 |
09/14/2021 | Translate Bio, Inc. | TBIO | Sale | Stock Option (right to buy) | 20k | $20.43 | $408.6k | | 09/14/2021 |
09/14/2021 | Translate Bio, Inc. | TBIO | Sale | Stock Option (right to buy) | 37.8k | $8.34 | $315.3k | | 09/14/2021 |
08/17/2021 | Spero Therapeutics, Inc. | SPRO | Grant | Stock Option (right to buy) | 7.5k | $13.69 | $102.7k | | 08/17/2021 |
06/28/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | | 26k | $127.02 | $3.3M | See Footnote | 06/28/2021 |
06/28/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | | 55.5k | $127.79 | $7.1M | See Footnote | 06/28/2021 |
06/28/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | | 56.3k | $128.77 | $7.2M | See Footnote | 06/28/2021 |
06/28/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | | 48.7k | $129.88 | $6.3M | See Footnote | 06/28/2021 |
06/28/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | | 66.5k | $130.79 | $8.7M | See Footnote | 06/28/2021 |
06/28/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | | 8k | $140.80 | $1.1M | See Footnote | 06/28/2021 |
06/28/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | | 8.4k | $141.66 | $1.2M | See Footnote | 06/28/2021 |
06/28/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | | 53.8k | $131.82 | $7.1M | See Footnote | 06/28/2021 |
06/28/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | | 13.6k | $142.88 | $1.9M | See Footnote | 06/28/2021 |
06/28/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | | 6.1k | $143.45 | $882.1k | See Footnote | 06/28/2021 |
06/28/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | | 56.2k | $132.77 | $7.5M | See Footnote | 06/28/2021 |
06/28/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | | 4.2k | $138.58 | $582.2k | See Footnote | 06/28/2021 |
06/28/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | | 52.3k | $139.96 | $7.3M | See Footnote | 06/28/2021 |
06/28/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | | 36.5k | $133.77 | $4.9M | See Footnote | 06/28/2021 |
06/28/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | | 30.8k | $134.86 | $4.2M | See Footnote | 06/28/2021 |
06/28/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | | 21.9k | $135.83 | $3M | See Footnote | 06/28/2021 |
06/28/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | | 3k | $137.01 | $415.6k | See Footnote | 06/28/2021 |
06/28/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | | 5.4k | $138.05 | $745.5k | See Footnote | 06/28/2021 |
06/23/2021 | Intellia Therapeutics, Inc. | NTLA | Grant | Stock Option (right to buy) | 3.4k | $83.59 | $282.7k | | 06/23/2021 |
06/23/2021 | Intellia Therapeutics, Inc. | NTLA | Grant | | 2.1k | $0.00 | $0 | | 06/23/2021 |
06/16/2021 | Translate Bio, Inc. | TBIO | Grant | Common Stock (right to buy) | 20k | $20.43 | $408.6k | | 06/16/2021 |
06/14/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | | 653 | $89.25 | $58.3k | 1See Footnote | 06/11/2021 |
|